discovery, this is the fourth deal between the two companies just in the last two years, sending biogenup more than 1% to 228.86. shares of blackberry rising, an investor may be close to buying the smartphone maker, according to times, their largest shareholder has put together billions in backing from canada's pension funds for a possible deal, pushing blackberry's stock up to $11.53. >>> and shares of delta higher as the stock gets ready. delta will replace bmc software, and stocks often move higher when they're added to major indices, delta rose 9%. >>> and some big health care changes coming to some big companies very soon. time warner and ibm, both announcing plans to move their retirees to private insurance exchanges, bertha coombs has more. >> reporter: big blue is making changes in how it pays for retiree health coverage. >> we projected health care costs in the current ibm plan will triple in the next few years, largely impacting your premiums and out of pocket costs. >> reporter: instead of offering a medicare supplement itself, ibm will give the retirees money in a health acc

let's have a look very quickly at today's big winner, or maybe not. >> how about regeneron, biogen. >tor. "street signs" begins right now. >> you know, today really does give new meaning to the words pay phone. nearly 140 billion in telecom deals sparking a fee frenzy. we'll talk about what all these changes mean, but also who is getting paid and i may have to eat humble pie. how hot are car sales, so hot you may not be able to get the car that you want. we'll lay out hottest of the hot

study of the american cancer society 422,000 women, the conclusion was women from 40 on who took biogenicecreased risk of breast cancer. it is very different and very conclusive to me. i have been on them for 16 years now. i think it has slowed down the aging process in me giving back my quality of life. gerri: how has your life improves? >> the three years ahead nor hormones, i looked everywhere in the house for them. i would weep for no reason. fly off the handle for no reason. i see the glass half full. bloating all the time, gaining weight. looking at myself and pictures in the "national enquirer" saying things like hirsute looks snug. you have to have them say your suit looks snug. everything made me mad. one day my husband, who i have been with since i was 19 years old who i adore said to me a marriage can only make to so muh of this. i thought i never thought i was that bad i never meant to take it out on you, so i went to the doctor, i was offered antidepressants, antianxiety, cholesterol lowering, sleeping pills. this cocktail they put women on that messes with our ability to be

close observers of this show should know these stocks cold, but it never hurts to remind people that biogennd celegene -- this is it a reminder of how well celegene has done. it's cheap on an earnings basis when you look at the out years. the blood cancer franchise is the biggest blockbuster going today. gilead is all about hepatitis c. bioagain idec, that stock is all about multiple sclerosis treatments that are taking off. and regeneron has the alternative for those who can't take traditional statens. they're going to have perfect performance, so the money is going to flow in. next up, linkedin, rallied $7.32 today. linkedin is an amazing company, it blew away the numbers. itting sell rates the revenue, no-brainer for these stock managers. how about these names, the cult stocks that people buy because they love the product. amazon up $5.40. netflix, yes, tesla. they're overvalued by any stretch of the imagination. people like to shop on amazon, they like netflix and they love the idea of driving a tesla. what can i say, in a bull market there are always stocks like these. the three musket

i know at that time, walter gilbert resigned from the harvard faculty to become the chief of biogen,he industrial corporate firm. but in acame back sense, he saw the real action occurring in the commercial sector, not the university sector at that time. congressman al gore started a series of hearings on the university industrial relations. yale and harvard at the time established rules for faculty and corporate relations. the long cherished myth that there was a sharp bifurcation between the production of knowledge and utilization of knowledge, the university and manufacturing company, that long shared ms. that the sharp between theexisted production and utilization of knowledge was no longer tenable. the question became how do you deal with that? there were layers of public interest and lurking in the background in this area of science was the custom of genetic engineering. if genetic engineering were to come possible and it seems as though it's becoming more possible with each day, how would it be governed? who would be involved? what kind of bodies would they be? would they be ab

we really made -- like at biogenerbi biogen. i can show you a number of companies like that. chesapeake. they're not bad guys, these founders. i think michael dell is a smart guy. that doesn't mean he's the right guy to run a company. it takes a different skill set. sometimes. not always. go ahead. i'm sorry. >> please finish. >> i'm just saying, it takes a different skill set. what really must happen is, mutual funds, these large funds, some are doing a good job now. some are becoming aware. but they should recognize they have a fiduciary duty here. they run billions and billions and billions of dollars of shareholder money. they should really take on the mayor responsibility of holding these guys responsible. and for the most part, some do. but for the most part, they sort of walk away from it. they'll paut a little proxy fwrp together or lean on some advisory firm to tell them how to vote. i think the voting in many cases is an extremely important thing they do. they want to somehow in many cases disavow that responsibility. and i think that should be something that could

biogen entering a six-year research collaboration with isa pharmaceutic pharmaceuticals. receive $100 million up front for that. bell helicopter, a unit of textron with lockheed martin to bid for the u.s. army's next generation helicopter an order worth billions of dollars and jacobs engineering will buy sinclair night for about $1.2 billion in cash. jacobs one of the largest constructing firms. the trading action up 117 points on the dow jones industrial average. i'm surprised at the amount of headline risk out there is not impacting the market this way the way as it was last week. >> seems to be on the bac burner although all the indications are -- >> although this is the busiest week. >> saw john harwood even if you just get the senate and not the house of representatives there's a chance the president may go ahead of this. traders seem to think all is perfectly calm. i want to point out because of the good news or the relative good news out of china and japan we have economically sensitive stocks stronger today. materials and industries they're leading the market. mat

. >> how about regeneron, biogen. >> i have a preview monitor. "street signs" begins right now. >> you know, today really does give new meaning to the words pay phone. nearly 140 billion in telecom deals sparking a fee frenzy. we'll talk about what all these changes mean, but also who is getting paid and i may have to eat humble pie. how hot are car sales, so hot you may not be able to get the car that you want. we'll lay out hottest of the hot models, plus forget about these strategic oil reserves, mandy, we'll talk about why some california farmers are rasin hell. >> a clever one. hello, everybody. good afternoon. we were on track for the best in august until president obama and speaker boehner weighed in on syria. we'll have secretary of state john kerry and defense secretary chuck hagel testifying in front of congress to make their case. the prospects of a u.s. strike against syria did help push the dow down 1.8% over the course of last week and the biggest drag on the dow right now, probably noticed the dow is in negative territory, microsof

these warnings affect glaxo smith clooins and roche biogen's.an eye on those stocks. >> thank you very much. take a look at the top five most shorted stocks in the s&p. number one, jc penney, perhaps not a surprise. 33% of the outstanding shares are held short. followed by cliffs natural with 32.3% short interest, u.s. steel, pite neny bows. see how they're fairing, green in the names with the exception of jc penney down almost 13% on the trading session. seeing lows not seen since 2001. stormy seas for carnival cruise lines. the operator falling for the second straight session after reporting a 30% drop in third quarter earnings and lowering its outlook for the current quarter. several brokerage firms downgrading the stock. the stock down about 10% year to date. a nice pop for men's warehouse shares. the retailer ceo speaking exclusively for the first time to our courtney reagan standing next to me following a high profile clash between him and the board. what did he say? >> interesting stuff. the men's warehouse founder george zimmer grabbed h

some big changes for biogen and e isis >>> some big health care changes coming to some very big companiesuncing they are planning to transfer their u.s. retirees to private insurance exchanges. bertha coombs with more information >>> big blue has long capped its rye retiree health care benefits. the costs are set to triple by 2020. they are switching to provide more choice and flexibility to their retirees at an equal or better cost. ibm will give their retirees money they can use toward plans, and part "d" drug coverage. a year ago, dupont made a similar move with its 80,000 medicare eligible employees moving them on to the health care exchange. that's the largest private medicare exchange which handles nearly half. providing them with agents who walk them through the process and find which plans, then them find which plans might be the most cost effective. retiree coverage among major pl employees has dropped. companies more than 500 employees according to mercer. extend health ceo says his health exchanges is continuing to provide coverage. >> it looked like an exchange way to help com

gilead, biogen, reagainer ron, celgene. seeing breakdown in financials. this worries me.n the last month it started slipping. now notably underperforming. trading activity in citi group. this has been going on for several weeks now. you see the decline. here what happens i'm worried about this week. we don't have a lot of positive catalysts. we're enthralled to washington and traders hate it when washington moves the stock market. lack of leadership here. yellen, cancel the speech for october 1stst in new york, bernanke on the sidelines and deal with the clean spending bill whether it's going to pass the house and senate. it's not a lot of positive catalysts for the market and it's showing in today's action. >> a heck of a month so far. amazing september. thanks, bob. >>> problems for carnival cruise lines, the ship christened by kate middleton taken out of service for repair. experienced a power outage sailing in the mediterranean. it does not know whether the ship will be ready for its next scheduled departure on september 27th. carnival ed scheduled to report earnings